Combined targeting of the BRD4-NUT-p300 axis in NUT midline carcinoma by dual selective bromodomain inhibitor, NEO2734
published in: Molecular Cancer Therapeutics
date of publication: 2020-05-05
main subject: NUT midline carcinoma
Cites articles
There is nothing here
Article - wd:Q94552514